Home
Conditions
Tetanus

Clinical trial condition

Tetanus

Explore clinical trials studying Tetanus. Study availability and eligibility vary by location and protocol.

272 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

Tetanus trial results

Completed

Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents

NCT01362322

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations: GSK Investigational Site Santiago, Chile

GSK Investigational Site Monterrey, Nuevo León, Mexico

GSK Investigational Site Estado de México, Mexico

View Trial Details

Completed

Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years

NCT00346073

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
Locations: GSK Investigational Site Huntsville, Alabama, United States

GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site Mesa, Arizona, United States

GSK Investigational Site Mesa, Arizona, United States

View all 42 locations

View Trial Details

Completed

Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children

NCT01988857

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
Locations: GSK Investigational Site Hanoi, Vietnam

View Trial Details

Completed

Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects

NCT00369824

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +24 more
Locations: GSK Investigational Site Mobile, Alabama, United States

GSK Investigational Site Chandler, Arizona, United States

GSK Investigational Site Mesa, Arizona, United States

GSK Investigational Site Jonesboro, Arkansas, United States

View all 50 locations

View Trial Details

Completed

Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine

NCT00258882

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +9 more
Locations: Oakland, California, United States

Aurora, Colorado, United States

Portland, Oregon, United States

View Trial Details

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults

NCT01755689

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +22 more
Locations: GSK Investigational Site Santo Domingo, Dominican Republic

GSK Investigational Site Tartu, Estonia

GSK Investigational Site Bangkok, Thailand

View Trial Details

Completed

Antitetanus Vaccination for People Older Than 65 Years.

NCT03266211

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Infections, +3 more
Locations: Service Urgence et Réanimation Pédiatrique Hôpital Femme Mère Enfant Groupement Hospitalier Est Bron, France

View Trial Details

Completed

Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine

NCT03552445

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +8 more
Locations: Not specified

View Trial Details

Completed

Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

NCT00611559

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations: GSK Investigational Site Murmansk, Russia

GSK Investigational Site Perm, Russia

GSK Investigational Site Syktyvkar, Russia

View Trial Details

Completed

Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine

NCT01086423

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
Locations: GSK Investigational Site Wuzhou, Guangxi, China

GSK Investigational Site Wuzhou, Guangxi, China

View Trial Details

Tetanus

Tetanus trial results

Related conditions